VNDA analyst estimates
Vanda Pharmaceuticals (VNDA) analyst ratings, the average price target and its range, and every firm's latest call.
- 3 firms rate VNDA: 2 buy, 1 hold, 0 sell.
- The average price target is $10.00 from None analysts, from $10.00 to $10.00.
VNDA analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Sep 23, 2026 | Oppenheimer | Vanda Pharmaceuticals initiated with an Outperform at Oppenheimer | $10.00 |
| May 11, 2026 | H.C. Wainwright | Vanda Pharmaceuticals price target lowered to $21 from $24 at H.C. Wainwright | $21.00 |
| Feb 23, 2026 | H.C. Wainwright | Vanda Pharmaceuticals price target raised to $24 from $22 at H.C. Wainwright | $24.00 |
| Jan 5, 2026 | H.C. Wainwright | Vanda Pharmaceuticals price target raised to $22 from $20 at H.C. Wainwright | $22.00 |
| Dec 31, 2025 | Jefferies | Vanda Pharmaceuticals price target raised to $7.50 from $5 at Jefferies | $7.50 |
| Nov 5, 2025 | B.Riley Financial | B.Riley Starts Vanda Pharmaceuticals (VNDA) at Buy | $11.00 |
| Jul 11, 2024 | Cantor Fitzgerald | Vanda Pharmaceuticals initiated with an Overweight at Cantor Fitzgerald | $11.00 |